Guloyan et al., 2020
Science Translational Medicine 8, 341ra76.CrossRefGoogle ScholarPubMed Sharma, AN, Ligade, SS, Sharma, JN, Shukla, P, Elased, KM and Lucot, JB (2015) GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats
"Many providers use BMI plus another risk factorsuch as a chronic disease diagnosisto determine whether people are eligible for a prescription
Start with low doses of both when combining
The proliferation of unauthorized manufacturers and online sellers can cause confusion among consumers, fuel market noise, and undermine trust in legitimate therapies
It has two mechanisms of action - both a GIP agonist and the GLP-1 agonist to work multiple pathways to aid in the potential to lose weight